ASTRAZENECA GETS CDSCO APPROVAL TO IMPORT REVOLUTIONARY ANTI-CANCER DRUG “LYNPARZA”
AstraZeneca Pharma India has received CDSCO approval to import its anti-cancer drug Lynparza (olaparib) in 100 mg and 150 mg…
olaparib
Read More
December 7, 2025
- ASG Eye Hospital to invest ₹2,000 crore to boost Nationwide Eye Care Access
- Gates Foundation Grants ₹1.3 Crore to Gujarat Biotechnology University for Pioneering Women’s Health Research
- Novo Nordisk to Introduce Ozempic in India This Month
- Uranium Traces Found in Breastmilk Across Bihar; Researchers Flag Possible Infant Health Risks